P. Worms

2.0k total citations
55 papers, 1.6k citations indexed

About

P. Worms is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, P. Worms has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cellular and Molecular Neuroscience, 31 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in P. Worms's work include Neuroscience and Neuropharmacology Research (34 papers), Receptor Mechanisms and Signaling (19 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). P. Worms is often cited by papers focused on Neuroscience and Neuropharmacology Research (34 papers), Receptor Mechanisms and Signaling (19 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). P. Worms collaborates with scholars based in France, Mexico and United States. P. Worms's co-authors include Kenneth G. Lloyd, Kathleen Bizière, G. Bartholini, B. Scatton, A. Pério, H. Depoortere, C.L.E. Broekkamp, J.P. Kan, Jean-Paul Terranova and P. L. Morselli and has published in prestigious journals such as Journal of Biological Chemistry, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

P. Worms

55 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Worms France 22 942 556 258 253 201 55 1.6k
Herbert H. Schneider Germany 26 969 1.0× 966 1.7× 342 1.3× 139 0.5× 316 1.6× 48 2.0k
O. Curet France 23 1.2k 1.3× 692 1.2× 279 1.1× 347 1.4× 255 1.3× 40 1.9k
J.C. Blanchard France 23 1.4k 1.5× 977 1.8× 264 1.0× 144 0.6× 92 0.5× 56 2.1k
Alain Boireau France 22 951 1.0× 546 1.0× 116 0.4× 519 2.1× 125 0.6× 72 1.6k
H.C. Guldberg Norway 19 902 1.0× 520 0.9× 204 0.8× 333 1.3× 175 0.9× 22 1.7k
H. Wachtel Germany 26 1.3k 1.4× 969 1.7× 123 0.5× 624 2.5× 358 1.8× 47 2.2k
P.E. Keane France 20 748 0.8× 459 0.8× 126 0.5× 111 0.4× 106 0.5× 41 1.4k
Taleen Hanania United States 24 738 0.8× 678 1.2× 313 1.2× 102 0.4× 152 0.8× 60 1.6k
Jean‐Paul Nicolas France 22 929 1.0× 834 1.5× 174 0.7× 120 0.5× 202 1.0× 30 1.8k
R J Baldessarini United States 28 946 1.0× 746 1.3× 161 0.6× 195 0.8× 229 1.1× 62 2.1k

Countries citing papers authored by P. Worms

Since Specialization
Citations

This map shows the geographic impact of P. Worms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Worms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Worms more than expected).

Fields of papers citing papers by P. Worms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Worms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Worms. The network helps show where P. Worms may publish in the future.

Co-authorship network of co-authors of P. Worms

This figure shows the co-authorship network connecting the top 25 collaborators of P. Worms. A scholar is included among the top collaborators of P. Worms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Worms. P. Worms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Worms, P.. (2001). The epidemiology of motor neuron diseases: a review of recent studies. Journal of the Neurological Sciences. 191(1-2). 3–9. 188 indexed citations
2.
Steinberg, R., Florence Oury-Donat, Jean-Paul Terranova, et al.. (1993). SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome. Psychopharmacology. 112(2-3). 219–227. 8 indexed citations
3.
Alonso, Richard, J.P. Kan, P. Worms, & Philippe Soubrié. (1990). Effects of repeated administration of tetrahydroaminoacridine (THA) on muscarinic receptor subtypes in the rat brain. Neurochemistry International. 17(3). 457–465. 5 indexed citations
4.
Mendre, Christiane, Marc Rodriguez, Marie‐Christine Galas, et al.. (1990). Pharmacological activity of cholecystokinin analogues modified in the Met28-Gly29 region. European Journal of Pharmacology. 186(2-3). 213–222. 5 indexed citations
5.
Pério, A., Jean-Paul Terranova, P. Worms, et al.. (1989). Specific modulation of social memory in rats by cholinomimetic and nootropic drugs, by benzodiazepine inverse agonists, but not by psychostimulants. Psychopharmacology. 97(2). 262–268. 109 indexed citations
6.
Schumacher, Cees A., R. Steinberg, J.P. Kan, et al.. (1989). Pharmacological characterization of the aminopyridazine SR 95639A, a selective M1 muscarinic agonist. European Journal of Pharmacology. 166(2). 139–147. 8 indexed citations
7.
Worms, P., et al.. (1989). Cholinomimetic activities of minaprine. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(4). 411–418. 30 indexed citations
8.
Wermuth, Camille G., Gilbert Schlewer, Jean Bourguignon, et al.. (1989). 3-Aminopyridazine derivatives with atypical antidepressant, serotonergic and dopaminergic activities. Journal of Medicinal Chemistry. 32(3). 528–537. 76 indexed citations
9.
Worms, P., et al.. (1989). Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats. Psychopharmacology. 98(2). 286–288. 27 indexed citations
10.
Jung, M., A. Pério, P. Worms, & Philippe Soubrié. (1988). Pharmacological characterization of the physostigmine stimulus in rats. Psychopharmacology. 95(4). 553–5. 9 indexed citations
11.
Jung, M., A. Pério, P. Worms, & Kathleen Bizière. (1988). Characterization of the scopolamine stimulus in rats. Psychopharmacology. 95(2). 195–9. 10 indexed citations
13.
Mendre, Christiane, Christiane Gueudet, Marie‐Christine Galas, et al.. (1988). A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.. Journal of Biological Chemistry. 263(22). 10641–10645. 11 indexed citations
14.
Jung, M., A. Pério, Jean-Paul Terranova, P. Worms, & Kathleen Bizière. (1987). Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats. European Journal of Pharmacology. 139(1). 111–116. 8 indexed citations
15.
Kan, J.P., et al.. (1987). SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.. Journal of Pharmacology and Experimental Therapeutics. 240(1). 251–258. 19 indexed citations
16.
Worms, P., et al.. (1982). gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.. Journal of Pharmacology and Experimental Therapeutics. 220(3). 660–671. 75 indexed citations
17.
Kg, Lloyd & P. Worms. (1981). Neuropharmacological actions of GABA agonists: predictability for their clinical usefulness.. PubMed. 29. 59–67. 1 indexed citations
18.
Lloyd, Kenneth G., P. Worms, B. Živković, B. Scatton, & G. Bartholini. (1980). Interaction of GABA mimetics with nigro-striatal dopamine neurons. Brain Research Bulletin. 5. 439–445. 18 indexed citations
19.
Kg, Lloyd & P. Worms. (1980). Sustained gamma-aminobutyric acid receptor stimulation and chronic neuroleptic effects.. PubMed. 24. 253–8. 7 indexed citations
20.
Worms, P. & Kenneth G. Lloyd. (1978). Differential blockade of bicuculline convulsions by neuroleptics. European Journal of Pharmacology. 51(1). 85–88. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026